Pfizer Inc (NYSE:PFE)

38.32
Delayed Data
As of 6:30pm ET
 +0.03 / +0.08%
Today’s Change
33.97
Today|||52-Week Range
44.90
-12.21%
Year-to-Date
Better Buy: Pfizer vs. Bristol-Myers Squibb
Dec 08 / MotleyFool.com - Paid Partner Content
Better Buy: Amgen vs. Pfizer
Dec 04 / MotleyFool.com - Paid Partner Content
3 Dividend Stocks You Can Safely Hold for Decades
Dec 06 / MotleyFool.com - Paid Partner Content
3 Top Growth Stocks to Buy in December
Dec 03 / MotleyFool.com - Paid Partner Content
Why Sorrento Therapeutics Was Right to Reject Takeover Bids With A 245% Premium
Dec 05 / MotleyFool.com - Paid Partner Content
Here's Why Lexicon Pharmaceuticals Is Tumbling Today
Dec 02 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close38.29
Today’s open38.10
Day’s range38.10 - 38.38
Volume14,971,279
Average volume (3 months)21,169,846
Market cap$211.9B
Data as of 6:30pm ET, 12/09/2019

Growth & Valuation

Earnings growth (last year)-46.78%
Earnings growth (this year)-1.55%
Earnings growth (next 5 years)+8.00%
Revenue growth (last year)+2.10%
P/E ratio13.4
Price/Sales4.86
Price/Book3.45

Competitors

 Today’s
change
Today’s
% change
NVSNovartis+0.46+0.50%
MRKMerck-0.13-0.15%
BMYBristol-Myers Squibb+1.33+2.22%
ABBVAbbVie-0.54-0.62%
Data as of 6:30pm ET, 12/09/2019

Financials

Next reporting dateJanuary 28, 2020
EPS forecast (this quarter)$0.57
Annual revenue (last year)$53.6B
Annual profit (last year)$11.2B
Net profit margin20.77%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
New York, New York

Forecasts